Compare BLFS & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLFS | ACHC |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2013 | 2011 |
| Metric | BLFS | ACHC |
|---|---|---|
| Price | $22.46 | $22.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $32.00 | $19.71 |
| AVG Volume (30 Days) | 344.0K | ★ 3.8M |
| Earning Date | 04-14-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 71.05 | ★ 1258.33 |
| EPS | N/A | ★ 0.82 |
| Revenue | $82,254,000.00 | ★ $3,153,963,000.00 |
| Revenue This Year | $18.45 | $4.87 |
| Revenue Next Year | $16.27 | $5.50 |
| P/E Ratio | ★ N/A | $25.41 |
| Revenue Growth | N/A | ★ 7.69 |
| 52 Week Low | $19.15 | $11.43 |
| 52 Week High | $29.57 | $33.58 |
| Indicator | BLFS | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 83.30 |
| Support Level | $20.34 | $20.88 |
| Resistance Level | $23.00 | $25.11 |
| Average True Range (ATR) | 0.86 | 1.00 |
| MACD | 0.10 | 0.69 |
| Stochastic Oscillator | 47.23 | 99.62 |
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.